This web page was created programmatically, to learn the article in its unique location you possibly can go to the hyperlink bellow:
https://www.nature.com/articles/s44360-026-00122-0
and if you wish to take away this text from our website please contact us
Berrington de Gonzalez, A. et al. Trends in most cancers incidence in youthful and older adults: a world comparative evaluation. Ann. Intern. Med. 178, 1677–1687 (2025).
Ugai, T. et al. Is early-onset most cancers an rising world epidemic? Current proof and future implications. Nat. Rev. Clin. Oncol. 19, 656–673 (2022).
Zhao, J. et al. Global developments in incidence, loss of life, burden and danger elements of early-onset most cancers from 1990 to 2019. BMJ Oncol. 2, e000049 (2023).
Sung, H. et al. Differences in most cancers charges amongst adults born between 1920 and 1990 within the USA: an evaluation of population-based most cancers registry knowledge. Lancet Public Health 9, e583–e593 (2024).
Gupta, S., May, F. P., Kupfer, S. S. & Murphy, C. C. Birth Cohort Colorectal Cancer (CRC): Implications for Research and Practice. Clin. Gastroenterol. Hepatol. 22, 455–469 (2024).
Downham, L. et al. Increase of early-onset colorectal most cancers: a cohort impact. J. Natl Cancer Inst. 118, 751–756 (2025).
Lee, H. Y. et al. The Cancer Spectrum Theory. Cancer Discov. 14, 589–593 (2024).
Park, S. et al. Association between screening and the thyroid most cancers “epidemic” in South Korea: proof from a nationwide examine. BMJ 355, i5745 (2016).
Fujiyoshi, Ok. et al. Opinion: Standardizing gene product nomenclature-a name to motion. Proc. Natl Acad. Sci. USA 118, e2025207118 (2021).
Akimoto, N. et al. Rising incidence of early-onset colorectal most cancers – a name to motion. Nat. Rev. Clin. Oncol. 18, 230–243 (2021).
Coorens, T. H. H. et al. The somatic mosaicism throughout human tissues community. Nature 643, 47–59 (2025).
Bleker, L. S., de Rooij, S. R., Painter, R. C., Ravelli, A. C. & Roseboom, T. J. Cohort profile: the Dutch famine beginning cohort (DFBC)- a potential beginning cohort examine within the Netherlands. BMJ Open 11, e042078 (2021).
Smith, N. R. et al. Associations between beginning weight and colon and rectal most cancers danger in maturity. Cancer Epidemiol. 42, 181–185 (2016).
Murphy, C. C. et al. Maternal weight problems, being pregnant weight acquire, and beginning weight and danger of colorectal most cancers. Gut 71, 1332–1339 (2022).
Mauri, G. et al. Early-onset cancers: organic bases and medical implications. Cell Rep. Med. 5, 101737 (2024).
Smith-Bindman, R. et al. Projected lifetime most cancers dangers from present computed tomography imaging. JAMA Intern. Med. 185, 710–719 (2025).
NCD Risk Factor Collaboration (NCD-RisC). Worldwide developments in body-mass index, underweight, chubby, and weight problems from 1975 to 2016: a pooled evaluation of 2416 population-based measurement research in 128.9 million youngsters, adolescents, and adults. Lancet 390, 2627–2642 (2017).
Friedenreich, C. M., Ryder-Burbidge, C. & McNeil, J. Physical exercise, weight problems and sedentary habits in most cancers etiology: epidemiologic proof and biologic mechanisms. Mol. Oncol. 15, 790–800 (2021).
Vashishtha, R. et al. Trends in adolescent consuming throughout 39 high-income nations: exploring the timing and magnitude of decline. Eur. J. Public Health 31, 424–431 (2021).
GBD 2019 Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable illness burden in 204 nations and territories, 1990-2019: a scientific evaluation from the Global Burden of Disease Study 2019. Lancet 397, 2337–2360 (2021).
Cao, Y. et al. Long-term use of antibiotics and danger of colorectal adenoma. Gut 67, 672–678 (2018).
Klein, E. Y. et al. Assessment of WHO antibiotic consumption and entry targets in 76 nations, 2000-15: an evaluation of pharmaceutical gross sales knowledge. Lancet Infect. Dis. 21, 107–115 (2021).
Mima, Ok. et al. The microbiome and rise of early-onset cancers: information gaps and analysis alternatives. Gut Microbes 15, 2269623 (2023).
Ronan, V., Yeasin, R. & Claud, E. C. Childhood improvement and the microbiome-the intestinal microbiota in upkeep of well being and improvement of illness throughout childhood improvement. Gastroenterology 160, 495–506 (2021).
Grech, A. et al. Maternal exposures and the toddler intestine microbiome: a scientific evaluation with meta-analysis. Gut Microbes 13, 1–30 (2021).
Laskar, R. S. et al. Genome-wide affiliation research and Mendelian randomization analyses present insights into the causes of early-onset colorectal most cancers. Ann. Oncol. 35, 523–536 (2024).
Hu, J., Ye, Y., Zhou, G. & Zhao, H. Using medical and genetic danger elements for danger prediction of 8 cancers within the UK Biobank. JNCI Cancer Spectr 8, pkae008 (2024).
Zhang, Y., Lindström, S., Kraft, P. & Liu, Y. Genetic danger, health-associated way of life, and danger of early-onset whole most cancers and breast most cancers. J. Natl Cancer Inst. 117, 40–48 (2025).
Shi, M., O’Brien, Ok. M. & Weinberg, C. R. Interactions between a polygenic danger rating and non-genetic danger elements in young-onset breast most cancers. Sci. Rep. 10, 3242 (2020).
Inamura, Ok. et al. Cancer as microenvironmental, systemic and environmental illnesses: alternative for transdisciplinary microbiomics science. Gut 71, 2107–2122 (2022).
Lochhead, P. et al. Etiologic subject impact: reappraisal of the sphere impact idea in most cancers predisposition and development. Mod. Pathol. 28, 14–29 (2015).
Swanton, C. et al. Embracing most cancers complexity: Hallmarks of systemic illness. Cell 187, 1589–1616 (2024).
Ogino, S., Chan, A. T., Fuchs, C. S. & Giovannucci, E. Molecular pathological epidemiology of colorectal neoplasia: an rising transdisciplinary and interdisciplinary subject. Gut 60, 397–411 (2011).
Ogino, S., Nowak, J. A., Hamada, T., Milner, D. A. Jr. & Nishihara, R. Insights into pathogenic interactions amongst surroundings, host, and tumor on the crossroads of molecular pathology and epidemiology. Annu. Rev. Pathol. 14, 83–103 (2019).
Li, Z. et al. The world, regional, and nationwide burden of early, center, and late-onset esophageal most cancers and developments from 1990 to 2021: a scientific evaluation of the Global Burden of Disease Study 2021. J. Thorac. Dis. 17, 8477–8496 (2025).
Codipilly, D. C. et al. Epidemiology and outcomes of young-onset esophageal adenocarcinoma: an evaluation from a population-based database. Cancer Epidemiol. Biomarkers Prev. 30, 142–149 (2021).
Drahos, J. et al. Age-specific danger issue profiles of adenocarcinomas of the esophagus: a pooled evaluation from the worldwide BEACON consortium. Int. J. Cancer 138, 55–64 (2016).
de Martel, C. et al. Helicobacter pylori an infection and the danger of improvement of esophageal adenocarcinoma. J. Infect. Dis. 191, 761–767 (2005).
Buckle, G. C. et al. Risk elements related to early-onset esophageal most cancers in Tanzania. JCO Glob. Oncol. 8, e2100256 (2022).
Kolb, J. M. et al. Early-onset esophageal adenocarcinoma presents with advanced-stage illness however has improved survival in contrast with older people. Gastroenterology 159, 2238–2240 (2020).
Wu, I. C. et al. Association between polymorphisms in cancer-related genes and early onset of esophageal adenocarcinoma. Neoplasia 13, 386–392 (2011).
Kasagi, Y. et al. Clinicopathological traits of esophageal squamous cell carcinoma in sufferers youthful than 50 years. Ann. Surg. Oncol. 22, 311–315 (2015).
Arnold, M. et al. Is gastric most cancers turning into a uncommon illness? A world evaluation of predicted incidence developments to 2035. Gut 69, 823–829 (2020).
Kang, S. J. et al. Impact of smoking and alcohol consumption on early-onset gastric most cancers improvement in younger Koreans: a population-based examine. J. Gastric Cancer 24, 145–158 (2024).
Juo, Y. Y. et al. Obesity is related to early onset of gastrointestinal cancers in California. J. Obes. 2018, 7014073 (2018).
Zhou, F., Shi, J., Fang, C., Zou, X. & Huang, Q. Gastric carcinomas in younger (youthful than 40 years) Chinese sufferers: clinicopathology, household historical past, and postresection survival. Medicine 95, e2873 (2016).
Grönberg, H., Bergh, A., Damber, J. E. & Emanuelsson, M. Cancer danger in households with hereditary prostate carcinoma. Cancer 89, 1315–1321 (2000).
Herrera-Pariente, C. et al. CTNND1 is concerned in germline predisposition to early-onset gastric most cancers by affecting cell-to-cell interactions. Gastric Cancer 27, 747–759 (2024).
LaPelusa, M. et al. Variation in therapy patterns of sufferers with early-onset gastric most cancers. Cancers 14, 3633 (2022).
Bergquist, J. R. et al. Early-onset gastric most cancers is a definite illness with worrisome developments and oncogenic options. Surgery 166, 547–555 (2019).
Liu, Y. et al. Trends, clinicopathological options, surgical therapy patterns and prognoses of early-onset versus late-onset gastric most cancers: a retrospective cohort examine. J. Adv. Res. 75, 697–705 (2025).
Lumish, M. A. et al. Clinical and molecular traits of early-onset vs average-onset esophagogastric most cancers. J. Natl Cancer Inst. 116, 299–308 (2024).
Zhao, B. et al. Clinicopathologic options, survival final result, and prognostic elements in gastric most cancers sufferers 18–40 years of age. J. Adolesc. Young Adult Oncol. 9, 514–521 (2020).
Moore, A. et al. Young-onset gastric most cancers and Epstein-Barr Virus (EBV) – a significant participant within the pathogenesis?. BMC Cancer 20, 34 (2020).
Cho, S. Y. et al. Sporadic early-onset diffuse gastric cancers have excessive frequency of somatic CDH1 alterations, however low frequency of somatic RHOA mutations in contrast with late-onset cancers. Gastroenterology 153, 536–549 (2017).
Setia, N. et al. Morphologic and molecular evaluation of early-onset gastric most cancers. Cancer 127, 103–114 (2021).
Morgan, E. et al. Global burden of colorectal most cancers in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut 72, 338–344 (2023).
Yasinzai, A. Q. Ok. et al. Trends and projected burden of early-onset gastrointestinal malignancies within the United States: a population-based evaluation (2001–2021). J. Natl Cancer Inst. 118, 250–260 (2026).
Liao, C. Ok. et al. Differences in traits and outcomes between early-onset colorectal most cancers and late-onset colorectal cancers. Eur. J. Surg. Oncol. 50, 108687 (2024).
Murphy, C. C. & Zaki, T. A. Changing epidemiology of colorectal most cancers – beginning cohort results and rising danger elements. Nat. Rev. Gastroenterol. Hepatol. 21, 25–34 (2024).
Spaander, M. C. W. et al. Young-onset colorectal most cancers. Nat. Rev. Dis. Primers 9, 21 (2023).
Nguyen, L. H. et al. Sedentary behaviors, TV viewing time, and danger of young-onset colorectal most cancers. JNCI Cancer Spectr 2, pky073 (2018).
O’Sullivan, D. E. et al. Risk Factors for early-onset colorectal most cancers: a scientific evaluation and meta-analysis. Clin. Gastroenterol. Hepatol. 20, 1229–1240 (2022).
Jin, E. H. et al. Sex and tumor-site variations within the affiliation of alcohol consumption with the danger of early-onset colorectal most cancers. J. Clin. Oncol. 41, 3816–3825 (2023).
Archambault, A. N. et al. Nongenetic determinants of danger for early-onset colorectal most cancers. JNCI Cancer Spectr. 5, pkab029 (2021).
Chen, H. et al. Metabolic syndrome, metabolic comorbid situations and danger of early-onset colorectal most cancers. Gut 70, 1147–1154 (2021).
Pan, Z. et al. Risk elements for early-onset colorectal most cancers: a large-scale Chinese cohort examine. J. Natl Cancer Cent. 3, 28–34 (2023).
Liu, P. H. et al. Association of weight problems with danger of early-onset colorectal most cancers amongst ladies. JAMA Oncol. 5, 37–44 (2019).
Li, H. et al. Associations of physique mass index at totally different ages with early-onset colorectal most cancers. Gastroenterology 162, 1088–1097 (2022).
Li, H., Boakye, D., Chen, X., Hoffmeister, M. & Brenner, H. Association of physique mass index with danger of early-onset colorectal most cancers: systematic evaluation and meta-analysis. Am. J. Gastroenterol. 116, 2173–2183 (2021).
Hur, J. et al. Sugar-sweetened beverage consumption in maturity and adolescence and danger of early-onset colorectal most cancers amongst ladies. Gut 70, 2330–2336 (2021).
Kim, H. et al. Total Vitamin D consumption and dangers of early-onset colorectal most cancers and precursors. Gastroenterology 161, 1208–1217 (2021).
Yue, Y. et al. Prospective analysis of dietary and way of life sample indices with danger of colorectal most cancers in a cohort of youthful ladies. Ann. Oncol. 32, 778–786 (2021).
Yuan, C. et al. Being breastfed in infancy and danger of colorectal most cancers and precursor lesions. Clin. Gastroenterol. Hepatol. 22, 1508–1517 (2024).
Stoffel, E. M. et al. Germline genetic options of younger people with colorectal most cancers. Gastroenterology 154, 897–905 (2018).
Pearlman, R. et al. Prevalence and spectrum of germline most cancers susceptibility gene mutations amongst sufferers with early-onset colorectal most cancers. JAMA Oncol. 3, 464–471 (2017).
Archambault, A. N. et al. Cumulative burden of colorectal cancer-associated genetic variants is extra strongly related to early-onset vs late-onset most cancers. Gastroenterology 158, 1274–1286 (2020).
Wang, H. et al. Identification of particular susceptibility loci for the early-onset colorectal most cancers. Genome Med. 15, 13 (2023).
Lawler, T., Parlato, L. & Warren Andersen, S. The histological and molecular traits of early-onset colorectal most cancers: a scientific evaluation and meta-analysis. Front. Oncol. 14, 1349572 (2024).
Ugai, T. et al. Immune cell profiles within the tumor microenvironment of early-onset, intermediate-onset, and later-onset colorectal most cancers. Cancer Immunol. Immunother. 71, 933–942 (2022).
Tsai, Y. Y. et al. Differences in tumor-associated T-cell receptor repertoires between early-onset and average-onset colorectal most cancers. J. Natl Cancer Inst. 116, 1645–1653 (2024).
Peng, T. & Zhan, Q. Single-cell integration evaluation reveals molecular signatures of the tumor microenvironment in early-onset colorectal most cancers. NPJ Precis. Oncol. 9, 360 (2025).
Janak, A. et al. Distinct metabolic and genetic alterations in tumors from early-onset versus late-onset colorectal most cancers. Free Radic. Biol. Med. 240, 773–782 (2025).
Matsuda, Ok. et al. Tumor vessel phenotype in colorectal most cancers microenvironment in response to age at prognosis. Br. J. Cancer. (2026).
Furuhashi, S. et al. Spatial profiling of cancer-associated fibroblasts of sporadic early onset colon most cancers microenvironment. NPJ Precis. Oncol. 7, 118 (2023).
Díaz-Gay, M. et al. Geographic and age variations in mutational processes in colorectal most cancers. Nature 643, 230–240 (2025).
Rosendahl Huber, A. et al. Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal most cancers. Cancer Cell 42, 487–496 (2024).
Barot, S. V. et al. Distinct intratumoral microbiome of young-onset and average-onset colorectal most cancers. EBioMedicine 100, 104980 (2024).
Kong, C. et al. Integrated metagenomic and metabolomic evaluation reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal most cancers. Gut 72, 1129–1142 (2023).
Yang, Y. et al. Dysbiosis of human intestine microbiome in young-onset colorectal most cancers. Nat. Commun. 12, 6757 (2021).
Qin, Y. et al. Consistent signatures within the human intestine microbiome of old- and young-onset colorectal most cancers. Nat. Commun. 15, 3396 (2024).
Adnan, D., Trinh, J. Q., Sharma, D., Alsayid, M. & Bishehsari, F. Early-onset colon most cancers exhibits a definite intestinal microbiome and a host-microbe interplay. Cancer Prev. Res. 17, 29–38 (2024).
Liu, J., Fang, W., He, X., Zhang, X. & Liu, H. Global burden of early-onset gallbladder and biliary tract most cancers from 1990 to 2021. BMC Gastroenterol. 25, 461 (2025).
Ariake, Ok. et al. Risk elements and traits of younger sufferers with the biliary tract carcinoma: outcomes of a mission examine for biliary surgical procedure by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J. Hepatobiliary Pancreat. Sci. 27, 571–580 (2020).
Anjali, Ok. et al. PARP1 rs1136410 (A/G) polymorphism is related to early age of onset of gallbladder most cancers. Eur. J. Cancer Prev. 31, 311–317 (2022).
Reddy, S. et al. Characteristics and medical outcomes in young-onset cholangiocarcinoma. Cancer Med. 12, 14094–14103 (2023).
Pappas, L. et al. The cholangiocarcinoma within the younger (CITY) examine: tumor biology, therapy patterns, and survival outcomes in adolescent younger adults with cholangiocarcinoma. JCO Precis. Oncol. 7, e2200594 (2023).
Jayakrishnan, T. et al. Molecular variations with therapeutic implications in early-onset in contrast with average-onset biliary tract cancers. JCO Precis. Oncol. 8, e2400138 (2024).
Guo, C. et al. Global epidemiology of early-onset liver most cancers attributable to particular aetiologies and danger elements from 2010 to 2019. J. Glob. Health 13, 04167 (2023).
GBD 2019 Hepatitis B Collaborators. Global, regional, and nationwide burden of hepatitis B, 1990–2019: a scientific evaluation for the Global Burden of Disease Study 2019. Lancet Gastroenterol. Hepatol. 7, 796–829 (2022).
Jing, W., Liu, J. & Liu, M. Global developments and regional variations in hepatitis C virus an infection prevalence and implications for prevention – worldwide, 1990–2017. China CDC Wkly 2, 564–569 (2020).
McGlynn, Ok. A., Petrick, J. L. & El-Serag, H. B. Epidemiology of hepatocellular carcinoma. Hepatology 73, 4–13 (2021).
Wan, D. W. et al. Risk elements for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B within the United States. Am. J. Gastroenterol. 106, 1994–2000 (2011).
Park, C. H. et al. Family historical past influences the early onset of hepatocellular carcinoma. World J. Gastroenterol. 18, 2661–2667 (2012).
Lessel, D. et al. Mutations in SPRTN trigger early onset hepatocellular carcinoma, genomic instability and progeroid options. Nat. Genet. 46, 1239–1244 (2014).
Yan, H. et al. Characterization of the genotype and integration patterns of hepatitis B virus in early- and late-onset hepatocellular carcinoma. Hepatology 61, 1821–1831 (2015).
Lv, T. et al. Clinical prognosis and associated molecular options of hepatitis B-associated adolescent and younger grownup hepatocellular carcinoma. Hum. Genomics 17, 52 (2023).
Yang, J. et al. Comprehensive genomic evaluation of early and late-onset hepatocellular carcinoma. Genes Dis. 11, 101031 (2024).
Huang, B. Z. et al. Rising incidence and racial disparities of early-onset pancreatic most cancers within the United States, 1995–2018. Gastroenterology 163, 310–312 (2022).
Huang, J. et al. Worldwide burden of, danger elements for, and developments in pancreatic most cancers. Gastroenterology 160, 744–754 (2021).
Yuan, C. et al. The age-dependent affiliation of danger elements with pancreatic most cancers. Ann. Oncol. 33, 693–701 (2022).
McWilliams, R. R. et al. Risk elements for early-onset and very-early-onset pancreatic adenocarcinoma: a pancreatic most cancers case-control consortium (PanC4) evaluation. Pancreas 45, 311–316 (2016).
Kang, J. S., Jang, J. Y., Kwon, W., Han, Y. & Kim, S. W. Clinicopathologic and survival variations in youthful sufferers with pancreatic ductal adenocarcinoma–a propensity score-matched comparative evaluation. Pancreatology 17, 827–832 (2017).
Castet, F. et al. Clinical and genomic characterisation of early-onset pancreatic most cancers. Eur. J. Cancer 194, 113338 (2023).
Takeda, T. et al. Early-onset pancreatic most cancers: Clinical traits and survival outcomes. Pancreatology 22, 507–515 (2022).
Ogobuiro, I. et al. Multiomic characterization reveals a definite molecular panorama in young-onset pancreatic most cancers. JCO Precis. Oncol. 7, e2300152 (2023).
Luciani, L. G., Cestari, R. & Tallarigo, C. Incidental renal cell carcinoma-age and stage characterization and medical implications: examine of 1092 sufferers (1982–1997). Urology 56, 58–62 (2000).
Su, X. et al. Global perception of early-onset genitourinary cancers in adolescents and adults from 1990 to 2021: temporal developments and well being inequalities analyses. World J. Surg. Oncol. 23, 208 (2025).
Chen, J., Dalerba, P., Terry, M. B. & Yang, W. Global weight problems epidemic and rising incidence of early-onset cancers. J. Glob. Health 14, 04205 (2024).
Leiba, A. et al. Adolescent weight problems and paternal nation of origin predict renal cell carcinoma: a cohort examine of 1.1 million 16 to 19-year-old males. J. Urol. 189, 25–29 (2013).
Hemminki, Ok. & Li, X. Age-specific familial dangers for renal cell carcinoma with proof on recessive heritable results. Kidney Int. 65, 2298–2302 (2004).
Truong, H. et al. Germline variants recognized in sufferers with early-onset renal cell carcinoma referred for germline genetic testing. Eur. Urol. Oncol. 4, 993–1000 (2021).
Clemmensen, T. et al. Pathologic and medical traits of early onset renal cell carcinoma. Hum. Pathol. 74, 25–31 (2018).
Suh, J. H. et al. Clinicopathologic options of renal cell carcinoma in younger adults: a comparability examine with renal cell carcinoma in older sufferers. Int. J. Clin. Exp. Pathol. 2, 489–493 (2009).
Lin, W., Ou, Y., Huang, H., Xie, R. & Huang, H. Epidemiology of early onset prostate most cancers: world patterns, danger elements, and projections by 2040. Ann. Surg. Oncol. (2026).
Lophatananon, A. et al. Dietary fats and early-onset prostate most cancers danger. Br. J. Nutr. 103, 1375–1380 (2010).
Al-Jebari, Y. et al. Risk of prostate most cancers for males fathering by assisted copy: nationwide inhabitants primarily based register examine. BMJ 366, l5214 (2019).
Hjelmborg, J. B. et al. The heritability of prostate most cancers within the Nordic Twin Study of Cancer. Cancer Epidemiol. Biomarkers Prev. 23, 2303–2310 (2014).
Brandt, A., Bermejo, J. L., Sundquist, J. & Hemminki, Ok. Age-specific danger of incident prostate most cancers and danger of loss of life from prostate most cancers outlined by the variety of affected relations. Eur. Urol. 58, 275–280 (2010).
Trendowski, M. R. et al. Germline variants in DNA injury restore genes and HOXB13 amongst black sufferers with early-onset prostate most cancers. JCO Precis. Oncol. 6, e2200460 (2022).
Pernar, C. H., Ebot, E. M., Wilson, Ok. M. & Mucci, L. A. The epidemiology of prostate most cancers. Cold Spring Harb. Perspect. Med. 8, a030361 (2018).
Gerhauser, C. et al. Molecular evolution of early-onset prostate most cancers identifies molecular danger markers and medical trajectories. Cancer Cell 34, 996–1011 (2018).
Chalmers, Z. R. et al. Early-onset metastatic and clinically superior prostate most cancers is a definite medical and molecular entity characterised by elevated TMPRSS2-ERG fusions. Prostate Cancer Prostatic Dis. 24, 558–566 (2021).
Bassette, E. & Ducie, J. A. Endometrial most cancers in reproductive-aged females: etiology and pathogenesis. Biomedicines 12, 886 (2024).
Wu, Z. et al. Molecular and medical insights into early-onset endometrial most cancers. Trends Cancer 11, 503–519 (2025).
Lortet-Tieulent, J., Ferlay, J., Bray, F. & Jemal, A. International patterns and developments in endometrial most cancers incidence, 1978–2013. J. Natl Cancer Inst. 110, 354–361 (2018).
Abdol Manap, N. et al. Endometrial most cancers in pre-menopausal ladies and youthful: danger elements and final result. Int. J. Environ. Res. Public Health 19, 9059 (2022).
Rosen, M. W. et al. Risk elements for endometrial most cancers or hyperplasia in adolescents and ladies 25 years previous or youthful. J. Pediatr. Adolesc. Gynecol. 32, 546–549 (2019).
Raglan, O. et al. Risk elements for endometrial most cancers: an umbrella evaluation of the literature. Int. J. Cancer 145, 1719–1730 (2019).
Haidopoulos, D. et al. Risk elements in ladies 40 years of age and youthful with endometrial carcinoma. Acta Obstet. Gynecol. Scand. 89, 1326–1330 (2010).
Setiawan, V. W. et al. Type I and II endometrial cancers: have they totally different danger elements?. J. Clin. Oncol. 31, 2607–2618 (2013).
Soliman, P. T. et al. Risk elements for younger premenopausal ladies with endometrial most cancers. Obstet. Gynecol. 105, 575–580 (2005).
Walsh, M. D. et al. Molecular, pathologic, and medical options of early-onset endometrial most cancers: figuring out presumptive Lynch syndrome sufferers. Clin. Cancer Res. 14, 1692–1700 (2008).
Choi, J. et al. Distinct genomic landscapes in early-onset and late-onset endometrial most cancers. JCO Precis. Oncol. 6, e2100401 (2022).
Makabe, T. et al. Genome-wide DNA methylation profile of early-onset endometrial most cancers: its correlation with genetic aberrations and comparability with late-onset endometrial most cancers. Carcinogenesis 40, 611–623 (2019).
Hu, Z. et al. Proteogenomic insights into early-onset endometrioid endometrial carcinoma: predictors for fertility-sparing remedy response. Nat. Genet. 56, 637–651 (2024).
Chen, Y. et al. Body mass index had totally different results on premenopausal and postmenopausal breast most cancers dangers: a dose-response meta-analysis with 3,318,796 topics from 31 cohort research. BMC Public Health 17, 936 (2017).
Cao, Y. et al. Association of physique fats distribution and danger of breast most cancers in pre- and postmenopausal ladies. Obes. Facts 16, 356–363 (2023).
Sopik, V. International variation in breast most cancers incidence and mortality in younger ladies. Breast Cancer Res. Treat. 186, 497–507 (2021).
Lima, S. M., Kehm, R. D. & Terry, M. B. Global breast most cancers incidence and mortality developments by area, age-groups, and fertility patterns. EClinicalMedicine 38, 100985 (2021).
Kehm, R. D., Yang, W., Tehranifar, P. & Terry, M. B. 40 years of change in age- and stage-specific most cancers incidence charges in US men and women. JNCI Cancer Spectr. 3, pkz038 (2019).
Al-Ajmi, Ok., Lophatananon, A., Ollier, W. & Muir, Ok. R. Risk of breast most cancers within the UK biobank feminine cohort and its relationship to anthropometric and reproductive elements. PLoS ONE 13, e0201097 (2018).
Bellanger, M., Lima, S. M., Cowppli-Bony, A., Molinié, F. & Terry, M. B. Effects of fertility on breast most cancers incidence developments: evaluating France and US. Cancer Causes Control 32, 903–910 (2021).
Lima, S. M., Kehm, R. D., Swett, Ok., Gonsalves, L. & Terry, M. B. Trends in parity and breast most cancers incidence in US ladies youthful than 40 years from 1935 to 2015. JAMA Netw. Open 3, e200929 (2020).
Sudan, S. Ok. et al. Obesity and early-onset breast most cancers and particular molecular subtype prognosis in black and white ladies: NIMHD Social Epigenomics Program. JAMA Netw. Open 7, e2421846 (2024).
Chen, W. Y., Rosner, B., Hankinson, S. E., Colditz, G. A. & Willett, W. C. Moderate alcohol consumption throughout grownup life, consuming patterns, and breast most cancers danger. JAMA 306, 1884–1890 (2011).
Chen, J., Kehm, R., Yang, W. & Terry, M. B. Increasing charges of early-onset Luminal A breast cancers correlate with binge consuming patterns. Breast Cancer Res. 26, 145 (2024).
Chan, D. S. M. et al. World Cancer Research Fund International: Continuous Update Project-systematic literature evaluation and meta-analysis of observational cohort research on bodily exercise, sedentary habits, adiposity, and weight change and breast most cancers danger. Cancer Causes Control 30, 1183–1200 (2019).
Godinho-Mota, J. C. M. et al. Sedentary Behavior and alcohol consumption enhance breast most cancers danger no matter menopausal standing: a case-control examine. Nutrients 11, 1871 (2019).
Farvid, M. S., Cho, E., Chen, W. Y., Eliassen, A. H. & Willett, W. C. Premenopausal dietary fats in relation to pre- and post-menopausal breast most cancers. Breast Cancer Res. Treat. 145, 255–265 (2014).
Zhu, J. W., Charkhchi, P., Adekunte, S. & Akbari, M. R. What is thought about breast most cancers in younger ladies?. Cancers 15, 1917 (2023).
Siddig, A. et al. The distinctive biology behind the early onset of breast most cancers. Genes 12, 372 (2021).
Anders, C. Ok. et al. Young age at prognosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J. Clin. Oncol. 26, 3324–3330 (2008).
Andrikopoulou, A. et al. The mutational panorama of early-onset breast most cancers: a next-generation sequencing evaluation. Front. Oncol. 11, 797505 (2021).
Dufour, O. et al. Early breast most cancers in ladies aged 35 years or youthful: a big nationwide multicenter French population-based case control-matched evaluation. Breast 68, 163–172 (2023).
Waks, A. G. et al. Somatic and germline genomic alterations in very younger ladies with breast most cancers. Clin. Cancer Res. 28, 2339–2348 (2022).
Toporcov, T. N. et al. Risk elements for head and neck most cancers in younger adults: a pooled evaluation within the INHANCE consortium. Int. J. Epidemiol. 44, 169–185 (2015).
Shewale, J. B. & Gillison, M. L. Dynamic elements affecting HPV-attributable fraction for head and neck cancers. Curr. Opin. Virol. 39, 33–40 (2019).
Révész, M. et al. The traits of head and neck squamous cell most cancers in younger adults: a retrospective single-center examine. Pathol. Oncol. Res. 29, 1611123 (2023).
Révész, M. et al. EZH2 expression in head-and-neck squamous cell most cancers in younger sufferers. Int. J. Mol. Sci. 25, 5250 (2024).
Patysheva, M. R. et al. Revealing molecular mechanisms of early-onset tongue most cancers by spatial transcriptomics. Sci. Rep. 14, 26255 (2024).
Zhang, H., Li, M., Zhao, L., Wang, L. & Geng, J. Epidemiological panorama of early-onset a number of myeloma: world burden, temporal developments, cross-country inequality, and projections to 2045. Hematology 30, 2576308 (2025).
Marinac, C. R. et al. Body mass index all through maturity, bodily exercise, and danger of a number of myeloma: a potential evaluation in three massive cohorts. Br. J. Cancer 118, 1013–1019 (2018).
Birmann, B. M. et al. Young grownup and common grownup physique mass index and a number of myeloma danger: a pooled evaluation within the International Multiple Myeloma Consortium (IMMC). Cancer Epidemiol. Biomarkers Prev. 26, 876–885 (2017).
Tanguay, M. et al. Young myeloma sufferers: a scientific evaluation of manifestations and outcomes. Curr. Oncol. 30, 5214–5226 (2023).
Martínez-Cordero, H. et al. Patients age 40 years and youthful with a number of myeloma have the identical prognosis as older sufferers: an evaluation of real-world sufferers’ proof from Latin America. JCO Glob. Oncol. 9, e2300182 (2023).
Ugai, T., van Guelpen, B., Mucci, L. A. & Ogino, S. Enhancing current tumour biobanks in European potential cohort research. Lancet Reg. Health Eur. 53, 101293 (2025).
Ogino, S. & Ugai, T. The world epidemic of early-onset most cancers: nature, nurture, or each?. Ann. Oncol. 35, 1071–1073 (2024).
Ogino, S., Ugai, S., Hamada, T. & Ugai, T. The early-onset most cancers epidemics: proof synthesis utilizing the potential cohort incident-tumor biobank methodology. Eur. J. Epidemiol. 40, 1405–1417 (2025).
Ogino, S., Patel, A. V., Ugai, S., Giannakis, M. & Ugai, T. Unique position of the potential cohort incident-tumor biobank methodology in etiological analysis. Lancet Reg. Health Am. 53, 101290 (2026).
Schernhammer, E. S. et al. Dietary folate, alcohol and B nutritional vitamins in relation to LINE-1 hypomethylation in colon most cancers. Gut 59, 794–799 (2010).
Antelo, M. et al. A excessive diploma of LINE-1 hypomethylation is a singular characteristic of early-onset colorectal most cancers. PLoS ONE 7, e45357 (2012).
Akimoto, N. et al. Tumor lengthy interspersed nucleotide element-1 (LINE-1) hypomethylation in relation to age of colorectal most cancers prognosis and prognosis. Cancers 13, 2016 (2021).
Ogino, S. et al. Prospective examine of household historical past and colorectal most cancers danger by tumor LINE-1 methylation stage. J. Natl Cancer Inst. 105, 130–140 (2013).
Liu, L. et al. Association between inflammatory weight loss program sample and danger of colorectal carcinoma subtypes labeled by immune responses to tumor. Gastroenterology 153, 1517–1530 (2017).
Cao, Y. et al. Regular aspirin use associates with decrease danger of colorectal cancers with low numbers of tumor-infiltrating lymphocytes. Gastroenterology 151, 879–892 (2016).
Arima, Ok. et al. Western-style weight loss program, pks Island-carrying Escherichia coli, and colorectal most cancers: analyses from two massive potential cohort research. Gastroenterology 163, 862–874 (2022).
Oeffinger, Ok. C. et al. Breast most cancers screening for ladies at common danger: 2015 guideline replace from the American Cancer Society. JAMA 314, 1599–1614 (2015).
Fontham, E. T. H. et al. Cervical most cancers screening for people at common danger: 2020 guideline replace from the American Cancer Society. CA Cancer J. Clin. 70, 321–346 (2020).
Wolf, A. M. D. et al. Colorectal most cancers screening for average-risk adults: 2018 guideline replace from the American Cancer Society. CA Cancer J. Clin. 68, 250–281 (2018).
Smith, R. A. et al. American Cancer Society pointers for the early detection of most cancers: replace of early detection pointers for prostate, colorectal, and endometrial cancers. Also: replace 2001–testing for early lung most cancers detection. CA Cancer J. Clin. 51, 38–75 (2001).
Wolf, A. M. et al. American Cancer Society guideline for the early detection of prostate most cancers: replace 2010. CA Cancer J. Clin. 60, 70–98 (2010).
Rugge, M. et al. Patients youthful than 40 years with gastric carcinoma: Helicobacter pylori genotype and related gastritis phenotype. Cancer 85, 2506–2511 (1999).
Clements, O., Eliahoo, J., Kim, J. U., Taylor-Robinson, S. D. & Khan, S. A. Risk elements for intrahepatic and extrahepatic cholangiocarcinoma: a scientific evaluation and meta-analysis. J. Hepatol. 72, 95–103 (2020).
Konstantinidis, I. T. et al. Trends in presentation and survival for gallbladder most cancers throughout a interval of greater than 4 a long time: a single-institution expertise. Arch. Surg. 144, 441–447 (2009).
Rawla, P., Sunkara, T., Thandra, Ok. C. & Barsouk, A. Epidemiology of gallbladder most cancers. Clin. Exp. Hepatol. 5, 93–102 (2019).
Hundal, R. & Shaffer, E. A. Gallbladder most cancers: epidemiology and final result. Clin. Epidemiol. 6, 99–109 (2014).
Sheth, S., Bedford, A. & Chopra, S. Primary gallbladder most cancers: recognition of danger elements and the position of prophylactic cholecystectomy. Am. J. Gastroenterol. 95, 1402–1410 (2000).
Calle, E. E., Rodriguez, C., Walker-Thurmond, Ok. & Thun, M. J. Overweight, weight problems, and mortality from most cancers in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348, 1625–1638 (2003).
Nodari, Y. et al. Genetic and non-genetic danger elements for early-onset pancreatic most cancers. Dig. Liver Dis. 55, 1417–1425 (2023).
Amadou, A. et al. Overweight, weight problems and danger of premenopausal breast most cancers in response to ethnicity: a scientific evaluation and dose-response meta-analysis. Obes. Rev. 14, 665–678 (2013).
Tran, T. X. M. et al. Adiposity, physique composition measures, and breast most cancers danger in Korean premenopausal ladies. JAMA Netw. Open 7, e245423 (2024).
Tran, T. X. M. et al. Height and breast most cancers danger in premenopausal Korean ladies aged beneath 40 years of age. Br. J. Cancer 131, 1913–1918 (2024).
Lynch, H. T., Watson, P., Conway, T., Fitzsimmons, M. L. & Lynch, J. Breast most cancers household historical past as a danger issue for early onset breast most cancers. Breast Cancer Res. Treat. 11, 263–267 (1988).
Russell, A., Mitchell, S., Turkington, R. C. & Coleman, H. G. Survival outcomes in early-onset oesophageal adenocarcinoma sufferers: a scientific evaluation and meta-analyses. World J. Gastroenterol. 30, 4221–4231 (2024).
Ge, Y. et al. Hypermethylation of EIF4E promoter is related to early onset of gastric most cancers. Carcinogenesis 39, 66–71 (2018).
Fontana, E. et al. Early-onset colorectal adenocarcinoma within the IDEA database: therapy adherence, toxicities, and outcomes with 3 and 6 months of adjuvant fluoropyrimidine and oxaliplatin. J. Clin. Oncol. 39, 4009–4019 (2021).
Jin, Z. et al. Clinicopathological and molecular traits of early-onset stage III colon adenocarcinoma: an evaluation of the ACCENT Database. J. Natl Cancer Inst. 113, 1693–1704 (2021).
Kanter, Ok. et al. Care patterns and general survival in sufferers with early-onset metastatic colorectal most cancers. JCO Oncol. Pract. 17, e1846–e1855 (2021).
Lipsyc-Sharf, M. et al. Survival in young-onset metastatic colorectal most cancers: findings from most cancers and leukemia group B (Alliance)/SWOG 80405. J. Natl Cancer Inst. 114, 427–435 (2022).
Meng, L. et al. Association of age with treatment-related hostile occasions and survival in sufferers with metastatic colorectal most cancers. JAMA Netw. Open 6, e2320035 (2023).
Suarez, J. et al. Higher price of pathologic full response in sufferers with early-onset domestically superior rectal most cancers. ESMO Gastrointestinal Oncol. 3, 100033 (2024).
Pretta, A. et al. Early onset metastatic colorectal most cancers sufferers as a particular medical and molecular phenomenon. Br. J. Cancer 132, 188–194 (2024).
Du, M. et al. Integrated multi-omics method to distinct molecular characterization and classification of early-onset colorectal most cancers. Cell Rep. Med. 4, 100974 (2023).
Lieu, C. H. et al. Comprehensive genomic landscapes in early and later onset colorectal most cancers. Clin. Cancer Res. 25, 5852–5858 (2019).
Ugai, T. et al. Molecular traits of early-onset colorectal most cancers in response to detailed anatomical places: comparability with later-onset instances. Am. J. Gastroenterol. 118, 712–726 (2023).
Antoniotti, C. et al. FOLFOXIRI and bevacizumab in sufferers with early-onset metastatic colorectal most cancers. A pooled evaluation of TRIBE and TRIBE2 research. Eur. J. Cancer 167, 23–31 (2022).
Li, J. S. et al. DNA methylation profiling at base-pair decision reveals distinctive epigenetic options of early-onset colorectal most cancers in underrepresented populations. Clin. Epigenetics 17, 11 (2025).
Nakamura, Ok. et al. A liquid biopsy signature for the detection of sufferers with early-onset colorectal most cancers. Gastroenterology 163, 1242–1251 (2022).
Georgeson, P. et al. Genotoxic colibactin mutational signature in colorectal most cancers is related to clinicopathological options, particular genomic alterations and higher survival. Preprint at medRxiv (2024).
This web page was created programmatically, to learn the article in its unique location you possibly can go to the hyperlink bellow:
https://www.nature.com/articles/s44360-026-00122-0
and if you wish to take away this text from our website please contact us
